Johnson & Johnson subsidiary gets Class I recall for implantable infusion pumps

Thu, 07/25/2013 - 11:29am
Mass Device

Codman & Shurtleff, a division of Johnson & Johnson subsidiary DePuy Synthes, gets the FDA's highest warning level for issues with certain lots of its programmable infusion pumps.

Johnson & Johnson subsidiary gets Class I recall for infusion pumps

The FDA puts its highest-risk label on a recall of programmable infusion pumps made by Codman & Shurtleff Inc., a division of Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics.

Codman's implanted MedStream pumps were recalled over a potential defect in a component that measures the contents of the pump reservoir. According to the company's estimates around 1% of the pumps are likely affected, and new shipments were halted while Codman resolves the issue.


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.